Ranked by reported Q1 2026 13F market value
Share of total reported institutional value in CUE held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | Bleichroeder LP | 6.8M | $1.6M | 0.0% | 259.488% | 0.27% |
| 2 | GC Wealth Management RIA, LLC | 4.6M | $1.1M | 0.0% | 176.247% | 0.04% |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | 2.5M | $565K | β | 93.513% | 0.00% |
| 4 | Lion Point Capital, LP | 2.2M | $506K | 0.0% | 83.825% | 3.03% |
| 5 | GEODE CAPITAL MANAGEMENT, LLC | 1.1M | $245K | +32.5% | 40.514% | 0.00% |
| 6 | VANGUARD FIDUCIARY TRUST CO | 544K | $125K | β | 20.685% | 0.00% |
| 7 | Robertson Stephens Wealth Management, LLC | 479K | $110K | 0.0% | 18.208% | 0.00% |
| 8 | BlackRock, Inc. | 449K | $103K | 0.0% | 17.092% | 0.00% |
| 9 | Texas Capital Bank Wealth Management Services Inc | 397K | $91K | -9.8% | 15.123% | 0.01% |
| 10 | ANGELES WEALTH MANAGEMENT, LLC | 310K | $71K | 0.0% | 11.796% | 0.00% |
| 11 | ADVISORY RESEARCH INC | 257K | $59K | 0.0% | 9.788% | 0.01% |
| 12 | STIFEL FINANCIAL CORP | 247K | $57K | 0.0% | 9.382% | 0.00% |
| 13 | Chicago Partners Investment Group LLC | 86K | $50K | 0.0% | 3.270% | 0.00% |
| 14 | RENAISSANCE TECHNOLOGIES LLC | 214K | $49K | -10.3% | 8.137% | 0.00% |
| 15 | BANK OF AMERICA CORP /DE/ | 208K | $48K | +0.1% | 7.904% | 0.00% |
| 16 | STATE STREET CORP | 179K | $41K | 0.0% | 6.825% | 0.00% |
| 17 | DIADEMA PARTNERS LP | 132K | $30K | β | 5.023% | 0.01% |
| 18 | NORTHERN TRUST CORP | 95K | $22K | -6.3% | 3.600% | 0.00% |
| 19 | UBS Group AG | 88K | $20K | +88.6% | 3.362% | 0.00% |
| 20 | GWM Advisors LLC | 20K | $20K | 0.0% | 0.761% | 0.00% |
| 21 | NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 80K | $18K | +914.0% | 3.025% | 0.00% |
| 22 | ADVISORTRUST PARTNERS, LLC | 50K | $11K | β | 1.903% | 0.00% |
| 23 | Sigma Planning Corp | 39K | $9K | -5.6% | 1.474% | 0.00% |
| 24 | GOLDMAN SACHS GROUP INC | 34K | $8K | +137.6% | 1.299% | 0.00% |
| 25 | Persistent Asset Partners Ltd | 33K | $8K | β | 1.270% | 0.00% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). β% of Fundβ shows how much of that investorβs total 13F portfolio is invested in CUE β a direct measure of their conviction.
Filings activity in CUE during Q1 2026, grouped by how each filer changed its position.
Institutions that opened a new CUE position in Q1 2026
Institutions that fully closed their CUE position in Q1 2026
8 quarters of 13F filings Β· Ξ columns show change vs prior quarter
| Quarter | Inst. Holders | Ξ Holders | Ownership % | Ξ Ownership | Total 13F Value | Ξ Value |
|---|---|---|---|---|---|---|
| Q1 2026 | 53 | +10% | 7.53% | 3.75 pp | $5M | 33% |
| Q4 2025 | 48 | 5.9% | 11.28% | 8.45 pp | $7M | 43% |
| Q3 2025 | 51 | +6.3% | 19.73% | +1.74 pp | $13M | +9.6% |
| Q2 2025 | 48 | 4.0% | 17.99% | +2.41 pp | $12M | +15% |
| Q1 2025 | 50 | 9.1% | 15.58% | 3.54 pp | $10M | 19% |
| Q4 2024 | 55 | +10% | 19.12% | +3.45 pp | $13M | +22% |
| Q3 2024 | 50 | 32% | 15.67% | 9.61 pp | $10M | 38% |
| Q2 2024 | 73 | β | 25.28% | β | $17M | β |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Ξ columns compare to the immediately prior filed quarter.
Latest Form 4 transactions by company officers and directors. Insider buys are widely viewed as the highest-conviction signal because executives are risking personal capital.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 1, 2026 | Lin Shao-Lee | Buy | 91K | $11.00 | $1000K |
Quick answers to the most common questions about buying CUE stock.
Based on Q1 2026 13F filings, institutional ownership of Cue Biopharma, Inc. stands at 7.5%, held across 53 reporting institutions.
Bleichroeder LP is the largest reported institutional holder of CUE, with approximately 6,819,164 shares worth $0.00B as of Q1 2026.
Yes β 1 widely-followed marquee investor appear among the top 25 institutional holders of CUE, including RENAISSANCE TECHNOLOGIES LLC.
Our composite Smart Money Score for CUE is 42 out of 100 (Neutral). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
14 institutions opened new positions in CUE during Q1 2026, while 9 fully exited. 4 added to existing positions and 35 trimmed.
CUE institutional ownership fell by 3.75 percentage points quarter-over-quarter, with a net change of +5 holders.
The top 10 institutions account for 90.0% of all reported 13F value in CUE, and the top 25 account for 99.2%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
Cue Biopharma, Inc. (CUE) Institutional Ownership